Vosoritide

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications

Publisher Correction: The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes.

Publisher Correction: The CNP analogue vosoritide mediates PDE2-sensitive anti-arrhythmogenic effects in mouse hearts with STZ-induced type 1 diabetes.

Journal: Basic research in cardiology
Published: April 27, 2026

Development of Muscle Function in Children with Achondroplasia Under Vosoritide Treatment: A Retrospective Single-Centre Observational Study.

Development of Muscle Function in Children with Achondroplasia Under Vosoritide Treatment: A Retrospective Single-Centre Observational Study.

Journal: Journal of musculoskeletal & neuronal interactions
Published: March 01, 2026

Update and review of treatment in achondroplasia.

Update and review of treatment in achondroplasia.

Journal: Anales de pediatria
Published: February 23, 2026

A Phase II Basket Trial of Vosoritide in Children with RASopathies, ACAN and NPR2 Deficiency.

A Phase II Basket Trial of Vosoritide in Children with RASopathies, ACAN and NPR2 Deficiency.

Journal: The Journal of clinical endocrinology and metabolism
Published: February 06, 2026

Key points of the International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with Achondroplasia

Key points of the International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with Achondroplasia

Journal: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
Published: February 01, 2026

Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs.

Achondroplasia management in the era of targeted therapies: a meta-analysis of C-type natriuretic peptide analogs.

Journal: Journal of the Endocrine Society
Published: January 29, 2026

Early Neonatal Administration of Vosoritide in Achondroplasia: A Report of Two Cases.

Early Neonatal Administration of Vosoritide in Achondroplasia: A Report of Two Cases.

Journal: American journal of medical genetics. Part A
Published: December 04, 2025

Real-world growth outcomes of vosoritide in children with achondroplasia: a single-center cohort study.

Real-world growth outcomes of vosoritide in children with achondroplasia: a single-center cohort study.

Journal: Journal of the Endocrine Society
Published: December 03, 2025

Sex-specific risk profiles of drug-associated joint stiffness and deformity: a FAERS-based pharmacovigilance study with Canadian Vigilance Adverse Reaction Database validation.

Sex-specific risk profiles of drug-associated joint stiffness and deformity: a FAERS-based pharmacovigilance study with Canadian Vigilance Adverse Reaction Database validation.

Journal: Clinical and experimental rheumatology
Published: November 20, 2025

Efficacy and safety of vosoritide in children with achondroplasia: a systematic review and meta-analysis.

Efficacy and safety of vosoritide in children with achondroplasia: a systematic review and meta-analysis.

Journal: European journal of pediatrics
Published: November 12, 2025

Practical guidance for clinicians to optimise orthopaedic outcomes in achondroplasia: International Achondroplasia Forum guiding principles.

Practical guidance for clinicians to optimise orthopaedic outcomes in achondroplasia: International Achondroplasia Forum guiding principles.

Journal: Bone
Published: November 11, 2025

Practical guidance for clinicians to optimise orthopaedic outcomes in achondroplasia: International achondroplasia forum guiding principles.

Practical guidance for clinicians to optimise orthopaedic outcomes in achondroplasia: International achondroplasia forum guiding principles.

Journal: Bone
Published: November 11, 2025
Showing 1-12 of 98

Last Updated: 06/30/2026